中国医药生物技术
中國醫藥生物技術
중국의약생물기술
CHINESE MEDICINAL BIOTECHNOLOGY
2015年
4期
289-293
,共5页
谢荃沁%陈陆俊%蒋敬庭%吴昌平
謝荃沁%陳陸俊%蔣敬庭%吳昌平
사전심%진륙준%장경정%오창평
癌,肝细胞%预后%血清酶
癌,肝細胞%預後%血清酶
암,간세포%예후%혈청매
Carcinoma%hepatocellular%Prognosis%Serum enzyme
目的 探讨原发性肝癌患者血清酶水平变化及预后意义.方法 收集苏州大学附属第三医院原发性肝癌患者术前血清样本147例、肝血管瘤患者33例、肝硬化患者36例、健康体检者79例,应用秩和检验比较谷丙转氨酶、谷草转氨酶、谷丙/谷草转氨酶比值、γ-谷氨酰转肽酶、碱性磷酸酶、乳酸脱氢酶和胆碱酯酶水平,分析谷丙转氨酶、谷草转氨酶与临床病理特征关系,Cox比例风险模型分析血清酶与患者预后关系.结果 谷丙转氨酶、谷草转氨酶、谷丙/谷草转氨酶比值、γ-谷氨酰转肽酶、碱性磷酸酶、乳酸脱氢酶和胆碱酯酶在肝癌、肝血管瘤、肝硬化者及健康体检者中差异有统计学意义,碱性磷酸酶、乳酸脱氢酶是原发性肝癌的独立预后因素.结论 血清酶在原发性肝癌的诊断和预后判断中具有重要价值.
目的 探討原髮性肝癌患者血清酶水平變化及預後意義.方法 收集囌州大學附屬第三醫院原髮性肝癌患者術前血清樣本147例、肝血管瘤患者33例、肝硬化患者36例、健康體檢者79例,應用秩和檢驗比較穀丙轉氨酶、穀草轉氨酶、穀丙/穀草轉氨酶比值、γ-穀氨酰轉肽酶、堿性燐痠酶、乳痠脫氫酶和膽堿酯酶水平,分析穀丙轉氨酶、穀草轉氨酶與臨床病理特徵關繫,Cox比例風險模型分析血清酶與患者預後關繫.結果 穀丙轉氨酶、穀草轉氨酶、穀丙/穀草轉氨酶比值、γ-穀氨酰轉肽酶、堿性燐痠酶、乳痠脫氫酶和膽堿酯酶在肝癌、肝血管瘤、肝硬化者及健康體檢者中差異有統計學意義,堿性燐痠酶、乳痠脫氫酶是原髮性肝癌的獨立預後因素.結論 血清酶在原髮性肝癌的診斷和預後判斷中具有重要價值.
목적 탐토원발성간암환자혈청매수평변화급예후의의.방법 수집소주대학부속제삼의원원발성간암환자술전혈청양본147례、간혈관류환자33례、간경화환자36례、건강체검자79례,응용질화검험비교곡병전안매、곡초전안매、곡병/곡초전안매비치、γ-곡안선전태매、감성린산매、유산탈경매화담감지매수평,분석곡병전안매、곡초전안매여림상병리특정관계,Cox비례풍험모형분석혈청매여환자예후관계.결과 곡병전안매、곡초전안매、곡병/곡초전안매비치、γ-곡안선전태매、감성린산매、유산탈경매화담감지매재간암、간혈관류、간경화자급건강체검자중차이유통계학의의,감성린산매、유산탈경매시원발성간암적독립예후인소.결론 혈청매재원발성간암적진단화예후판단중구유중요개치.
Objective To investigate the variation of serum enzyme levels in primary hepatic carcinoma and their significances of prognosis. Methods Preoperative serum of 147 hepatic carcinoma, 33 hepatic hemangioma, 36 hepatic cirrhosis patients and 79 healthy individuals were collected. The rank sum test was used to compare the levels of GPT, GOT, GPT/GOT,γ-GT, ALP, LDH and ChE. The levels of GPT and GOT were compared with clinical pathology features. The Cox proportional hazards model was used to analyze the relationship between prognosis and serum enzyme levels. Results The levels of GPT, GOT, GPT/GOT,γ-GT, ALP, LDH and ChE were discrepant in different patient groups and the control group, with statistically significance. ALP and ChE levels were independent factors for the prognosis of primary hepatic carcinoma. Conclusion The levels of serum enzyme have important value in diagnosis and prognosis criterion of primary hepatic carcinoma.